Substituted acylhydroxamic acids and method of reducing TNFαlevels
Imido and amido substituted acylhydroxamidic acids which reduce the levels of TNFα and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propandylamino)propanoate.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
18.03.2008
|
Online Access | Get full text |
Cover
Loading…
Abstract | Imido and amido substituted acylhydroxamidic acids which reduce the levels of TNFα and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propandylamino)propanoate. |
---|---|
AbstractList | Imido and amido substituted acylhydroxamidic acids which reduce the levels of TNFα and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propandylamino)propanoate. |
Author | Man, Hon-Wah Huang, Shaei Y Muller, George W |
Author_xml | – sequence: 1 givenname: Hon-Wah surname: Man fullname: Man, Hon-Wah – sequence: 2 givenname: George W surname: Muller fullname: Muller, George W – sequence: 3 givenname: Shaei Y surname: Huang fullname: Huang, Shaei Y |
BookMark | eNrjYmDJy89L5WRwDi5NKi7JLCktSU1RSEyuzMmoTCnKr0jMzUwGcjNTihUS81IUclNLMvJTFPLTFIpSU0qTM_PSFUL83M5tzEktS80p5mFgTUvMKU7lhdLcDApuriHOHrqlxQWJJal5JcXx6UWJIMrA3NjE1MDMyJgIJQDFrTX9 |
ContentType | Patent |
CorporateAuthor | Celgene Corporation |
CorporateAuthor_xml | – name: Celgene Corporation |
DBID | EFH |
DatabaseName | USPTO Issued Patents |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EFH name: USPTO Issued Patents url: http://www.uspto.gov/patft/index.html sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
ExternalDocumentID | 07345062 |
GroupedDBID | EFH |
ID | FETCH-uspatents_grants_073450623 |
IEDL.DBID | EFH |
IngestDate | Sun Mar 05 22:31:06 EST 2023 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-uspatents_grants_073450623 |
OpenAccessLink | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7345062 |
ParticipantIDs | uspatents_grants_07345062 |
PatentNumber | 7345062 |
PublicationCentury | 2000 |
PublicationDate | 20080318 |
PublicationDateYYYYMMDD | 2008-03-18 |
PublicationDate_xml | – month: 03 year: 2008 text: 20080318 day: 18 |
PublicationDecade | 2000 |
PublicationYear | 2008 |
References | Borkakoti, Matrix Metalloproteases: Variations on a Theme, Progress in Biophysics & Molecular Biology, 1998, vol. 70, No. 1, pp. 73-94. Man et al. (7034052) 20060400 Yu et al., Matrix Metalloproteases: Novel Targets for Directed Cancer Therapy, Drugs & Aging, Sep. 1997, vol. 11, No. 3, pp. 229-244. |
References_xml | – year: 20060400 ident: 7034052 contributor: fullname: Man et al. |
Score | 2.7035615 |
Snippet | Imido and amido substituted acylhydroxamidic acids which reduce the levels of TNFα and inhibit phosphodiesterase in a mammal. A typical embodiment is... |
SourceID | uspatents |
SourceType | Open Access Repository |
Title | Substituted acylhydroxamic acids and method of reducing TNFαlevels |
URI | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7345062 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NSgMxEB5qEdSTomL9Iwev0dTNprvn0mURLD1U6K3kV4V1t-xu0T6WL-IzOdlI8aLHJDAZEmYmk3z5BuBGY9BLlYipNmlCOVeaypGQVEnupNVGps5f6D9ORf7EHxbxogf59i_MG5oRXaEuze26WbVVB65E9x42ngbyZ88RWHr2gfeyqKSZGXc3injMvDPeSZiHdk2y_AD2UAQe2cq2-RU0skPYnXW9R9Cz5TGMvY2Gh3lDpN4ULxtTVx--Hjw2X01DMKknoaIzqRypPakqBhYyn2Zfn4UH9zQnQLLJfJzT7YzL59ojWZbsR7PoFPqY0dszIEkqneA2YtYyPmRK8Y5WLbpXNmXCugEM_hRz_s_YBewHOENEh8kl9Nt6ba8wZrbquluQb4qtedw |
link.rule.ids | 230,309,786,808,891,64394 |
linkProvider | USPTO |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgXicQIAYzxy4BjKadu15rCqvqoch7VYlTQJIpZ3aTrCfxR_hNxG3aOICxySSYyWyvzhxPgNcZBb0Aum5NFOBTzmXGRUjT1ApuBE6UyIweKH_GHvRE7-bubMeRKu_MG_WjOjc6lJfLup5U7bJlda9dxtPO_Jn5AgskH3gvchLoRJlrkYOdxk64zXEWGTRn4TRNmxaIfbQVjT1L9gId2A9aXt3oaeLPRijlXZP84qIbJm_LFVVfmBFeNt8VTWxYT3pajqT0pAKaVUttJBpHH595pjeU-8DCSfTcURXM6bPFeaypOxHN-cA-jam14dA_EAYj2uHac34kEnJW2I151rqgHnaDGDwp5ijf8bOYSO5CdOH2_j-GLa63AaHDv0T6DfVQp9aAG3kWbs236wufNY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+acylhydroxamic+acids+and+method+of+reducing+TNF%CE%B1levels&rft.inventor=Man%2C+Hon-Wah&rft.inventor=Muller%2C+George+W&rft.inventor=Huang%2C+Shaei+Y&rft.number=7345062&rft.date=2008-03-18&rft.externalDBID=n%2Fa&rft.externalDocID=07345062 |